HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Novitzky, D. Articles by Zuhdi, N. Search for Related Content PubMed PubMed Citation Articles by Novitzky, D. Articles by Zuhdi, N.

Ann Thorac Surg 1991;51:10-17
© 1991 The Society of Thoracic Surgeons

---

Articles

Triiodothyronine in the recovery of stunned myocardium in dogs

^a Oklahoma Transplantation Institute, Baptist Medical Center, Oklahoma City, Japan
^b School of Veterinary Medicine, Oklahoma State University, Stillwater, Oklahoma Japan

^_* Address reprint requests to Dr Novitzky, Oklahoma Transplantation Institute, Baptist Medical Center, 3300 NW Expressway, Oklahoma City, OK 73112.

Two groups of dogs were subjected to a 15-minute period of regional myocardial ischemia by snaring the left anterior descending coronary artery proximal to its first diagonal branch. After release of the snare, the dogs were given either placebo (group 1: n = 7) or triiodothyronine (T₃) therapy (group 2: n = 6). The dose of T₃ given was 0.2 µg/kg at 30-minute intervals to a total of six doses. Plasma free T₃ level fell significantly during the ischemic period in both groups and continued to fall after reperfusion in group 1. In both groups, cardiac function deteriorated significantly during the period of ischemia and rapidly returned to control level after reperfusion. After 90 minutes of reperfusion, however, deterioration of left ventricular function was observed in group 1 and was significantly worse than in group 2, in which hemodynamic function was maintained and, in fact, improved to levels superior to control. It is suggested that T₃ therapy may be worthy of trial in patients in whom reperfusion of the myocardium takes place after a relatively short ischemic period (the "stunned myocardium").

This article has been cited by other articles:

				M. Sirlak, L. Yazicioglu, M. B. Inan, S. Eryilmaz, R. Tasoz, A. Aral, and U. Ozyurda Oral thyroid hormone pretreatment in left ventricular dysfunction Eur J Cardiothorac Surg, October 1, 2004; 26(4): 720 - 725. [Abstract] [Full Text] [PDF]

				M. Minakawa, K. Takeuchi, K. Ito, T. Tsushima, K. Fukui, S. Takaya, and I. Fukuda Restoration of sarcoplasmic reticulum protein level by thyroid hormone contributes to partial improvement of myocardial function, but not to glucose metabolism in an early failing heart Eur J Cardiothorac Surg, October 1, 2003; 24(4): 493 - 501. [Abstract] [Full Text] [PDF]

				R. Salenger, J. S. Gammie, and T. J. Vander Salm Postoperative Care of Cardiac Surgical Patients Card. Surg. Adult, January 1, 2003; 2(2003): 439 - 469. [Full Text]

				T. V. Votapka, D. A. Canvasser, D. G. Pennington, M. Koga, and M. T. Swartz Effect of Triiodothyronine on Graft Function in a Model of Heart Transplantation Ann. Thorac. Surg., July 1, 1996; 62(1): 78 - 82. [Abstract] [Full Text]

				E. Bennett-Guerrero, J. L. Jimenez, W. D. White, E. B. D'Amico, B. I. Baldwin, D. A. Schwinn, Duke T3 Study Group, N. P. Bouknight, C. M. Chuey, F. M. Clements, et al. Cardiovascular Effects of Intravenous Triiodothyronine in Patients Undergoing Coronary Artery Bypass Graft Surgery: A Randomized, Double-blind, Placebo-Controlled Trial JAMA, March 6, 1996; 275(9): 687 - 692. [Abstract] [PDF]

				J. D. Walker, F. A. Crawford Jr., R. Mukherjee, and F. G. Spinale THE DIRECT EFFECTS OF 3,5,3'-TRIIODO-L-THYRONINE (T3) ON MYOCYTE CONTRACTILE PROCESSES: Insights into mechanisms of action J. Thorac. Cardiovasc. Surg., November 1, 1995; 110(5): 1369 - 1380. [Abstract] [Full Text]

				J. D. Klemperer, J. Zelano, R. E. Helm, K. Berman, K. Ojamaa, I. Klein, O. W. Isom, and K. Krieger Triiodothyronine improves left ventricular function without oxygen wasting effects after global hypothermic ischemia J. Thorac. Cardiovasc. Surg., March 1, 1995; 109(3): 457 - 465. [Abstract] [Full Text]

				B. Murzi, G. Iervasi, S. Masini, R. Moschetti, V. Vanini, G. Zucchelli, and A. Biagini Thyroid hormones homeostasis in pediatric patients during and after cardiopulmonary bypass Ann. Thorac. Surg., February 1, 1995; 59(2): 481 - 485. [Abstract] [PDF]

				J. D. Walker, F. A. Crawford, S. Kato, and F. G. Spinale The novel effects of 3,5,3'-triiodo-L-thyronine on myocyte contractile function and {beta}-adrenergic responsiveness in dilated cardiomyopathy J. Thorac. Cardiovasc. Surg., October 1, 1994; 108(4): 672 - 679. [Abstract] [Full Text]

				M. Kadletz, P. G. Mullen, M. Ding, L. G. Wolfe, and A. S. Wechsler Effect of triiodothyronine on postischemic myocardial function in the isolated heart Ann. Thorac. Surg., March 1, 1994; 57(3): 657 - 662. [Abstract] [PDF]

				C. M. Dyke, M. Ding, A. S. Abd-Elfattah, K. Loesser, R. J. Dignan, A. S. Wechsler, and D. R. Salter Effects of triiodothyronine supplementation after myocardial ischemia Ann. Thorac. Surg., August 1, 1993; 56(2): 215 - 222. [Abstract] [PDF]

				C. M. Dyke, T. Yeh Jr, J. D. Lehman, A. Abd-Elfattah, M. Ding, A. S. Wechsler, and D. R. Salter Triiodothyronine-enhanced left ventricular function after ischemic injury Ann. Thorac. Surg., July 1, 1991; 52(1): 14 - 19. [Abstract] [PDF]

				R. E. Clark Triiodothyronine: To be or not to be, that is the question Ann. Thorac. Surg., January 1, 1991; 51(1): 5 - 5. [PDF]